Molnupiravir: The Game-Changing Antiviral Pill for COVID-19?

Pharmaceutical company Merck applied on October 11 for FDA emergency use authorization for its oral antiviral COVID-19 drug, molnupiravir. In this Q&A, Carl Dieffenbach, PhD, director of the Division of AIDS at the National Institute of Allergy and Infectious Diseases, and Joshua Sharfstein, MD, talk about the development of the medication, how […]

Read More

Regen-cov: el primer tratamiento antiviral que demuestra salvar vidas de enfermos graves con covid

Un caro cóctel de anticuerpos ajenos evita una muerte por cada 17 pacientes tratados, según los resultados del mayor ensayo clínico del mundo. La humanidad desarrolló en tiempo récord vacunas para evitar la covid, pero acumula fracasos en la carrera para encontrar un tratamiento eficaz para las personas que ya tienen […]

Read More

Researchers race to develop antiviral weapons to fight the pandemic coronavirus

Science’s COVID-19 reporting is supported by the Heising-Simons Foundation. In March 2020, as the scope of the COVID-19 pandemic was coming into view, Jen Nwankwo and colleagues turned a pair of artificial intelligence (AI) tools against SARS-CoV-2. One newly developed AI program, called SUEDE, digitally screens all known druglike compounds […]

Read More